cyc 202 has been researched along with Recrudescence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, CE; Edwards, J; Fyffe, G; Heng, SJ; Horgan, PG; Leung, HY; McCall, P; Seywright, M; Tannahill, C; Underwood, MA; Willder, JM | 1 |
1 other study(ies) available for cyc 202 and Recrudescence
Article | Year |
---|---|
Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.
Topics: Aged; Biomarkers, Tumor; CDC2 Protein Kinase; Disease-Free Survival; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Purines; Receptors, Androgen; Recurrence; Roscovitine; Serine | 2013 |